臨床試験Nctページ

Clinical Trial Results:
A pilot, randomized, double-blind, placebo-controlled, crossover study evaluating the efficacy and safety of Vardenafil versus placebo administered 12, 18 and 24 hours prior to initiation of sexual intercourse in subjects with ED.

Summary
EudraCT number	2004-001549-13
Trial protocol	IT
Global completion date	07 Dec 2004

Paediatric regulatory details
Is the trial part of an agreed EMA paediatric investigation plan?	No
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?	No
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?	No

Results information
Results version number	v1(current)
This version publication date	28 Aug 2016
First version publication date	28 Aug 2016
Other versions
Summary report(s)	Bayer Study Synopsis

Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.

臨床試験Nctページ

Clinical Trial Results:
A pilot, randomized, double-blind, placebo-controlled, crossover study evaluating the efficacy and safety of Vardenafil versus placebo administered 12, 18 and 24 hours prior to initiation of sexual intercourse in subjects with ED.

スポンサーと協力者

医学的状態

薬物療法

臨床試験Nctページ

Clinical Trial Results: A pilot, randomized, double-blind, placebo-controlled, crossover study evaluating the efficacy and safety of Vardenafil versus placebo administered 12, 18 and 24 hours prior to initiation of sexual intercourse in subjects with ED.

スポンサーと協力者

医学的状態

薬物療法

Clinical Trial Results:
A pilot, randomized, double-blind, placebo-controlled, crossover study evaluating the efficacy and safety of Vardenafil versus placebo administered 12, 18 and 24 hours prior to initiation of sexual intercourse in subjects with ED.